Faculty

Institution

Unit

Venue

Kelly Langert

Assistant Professor

Loyola University Chicago

Affiliations

Stritch School of Medicine

Molecular Pharmacology and Neurosciences

Kelly Langert is currently serving as a Molecular Pharmacology And Neurosciences Assistant Professor at Loyola University Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kelly Langert

Loyola University Chicago

Assistant Professor

You can click a keyword to filter the displayed items

pharmacology neuroscience cell biology gene expression neurology drug delivery nanoparticles cell signaling vascular biology visual science angiogenesis trabecular meshwork cell regulation experimental ophthalmology nanotechnology tissue (biology) nanoparticle research cell growth protein secretion vision research experimental autoimmune neuritis nanomaterials polymer science pharmacotherapy pharmaceutics cellular physiology liver physiology polymer nanotechnology cell proliferation pharmaceutical chemistry pharmaceutical sciences therapeutic nanomaterials corneal epithelial cells prenylated flavonoid additive manufacturing applied pharmacology biopolymers pharmacological research free radical biology cell research experimental medicine plant physiology clinical lipidology biomaterials design peripheral nervous system peripheral nerve membrane technology protective coatings benchmark studies surface nanotechnology neurochemistry neuroinflammation pharmaceutical nanotechnology pharmaceutical practice pharmaceutical care lymphatic system vascular disease vascular pharmacology drug targeting signaling pathways targeted delivery plasma membrane vesicles polymeric nanoparticles critical parameters lovastatin-encapsulating poly acid nanoparticle formulations finely-tuned size distributions lactic-co-glycolic acid rho gtpase rala gtpases tnf-a mediated secretion lymphocyte composition antioxidant effects neuropsychopharmacology neuroprotection neuroimmunology molecular neuroscience neuropharmacology molecular neurodegeneration inflammatory neuropathies

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4143957: Assessing Blood-Nerve Barrier Permeability to Nanoparticles Over the Course of Experimental Autoimmune Neuritis. Circulation (2024)

Chanpreet KaurMaleen CabeKelly Langert

immunologyexperimental autoimmune neuritisautoimmune diseasesneuroimmunologynanoparticlesblood-nerve barrier permeability

Blood Nerve Barrier Permeability Enables Nerve Targeting of Circulating Nanoparticles in Experimental Autoimmune Neuritis. Research Square (Research Square) (2024)

Kelly LangertChanpreet KaurEllaina VillarrealMaleen Cabe

immunologyneurologyexperimental autoimmune neuritisnanotechnologyneuroscience

Statin Targeted Treatment Against Intimal Hyperplasia Using Unique Chitosan-Plga Nanoparticles. JVS Vascular Science (2024)

Ashley PentonGloria Grace PolandMaleen CabeKelly LangertKristopher MaierVivian Gahtan

intimal hyperplasiananomedicinebiomedical engineeringunique chitosan-plga nanoparticlesvascular biologynanoparticle researchvascular diseasenanoparticlesvascular pharmacology

Targeted Drug Delivery of Leukomimetic Nanoparticles to Alleviate Peripheral Neuropathy in Charcot-Marie-Tooth 1x. Journal of Pharmacology and Experimental Therapeutics (2024)

Harshita KondetiMaleen CabeLauren SoehlkeKelly LangertCharles Abrams

neurologypharmacologynanomedicineperipheral neuropathydrug targetingleukomimetic nanoparticlesdrug delivery

Beyond Cholesterol Reduction: Statin Pleiotropy and Peripheral Arterial Disease. IntechOpen eBooks (2023)

Ashley PentonKelly A. LangertKristopher MaierVivian Gahtan

cardiologyperipheral arterial diseaseclinical lipidologypharmacologystatin pleiotropyhematologynephrologycholesterol reductioncardiovascular diseasehealth scienceshealth policy

Chitosan/Poly(Lactic-Co-Glycolic)Acid Nanoparticle Formulations With Finely-Tuned Size Distributions for Enhanced Mucoadhesion. Pharmaceutics (2022)

Feipeng YangMaleen CabeHope A. NowakKelly A. Langert

materials sciencepharmaceutical chemistryapplied pharmacologynanoparticlespharmaceutical sciencesacid nanoparticle formulationspolymer nanotechnologymedicinefinely-tuned size distributionstherapeutic nanomaterialsdrug deliverynanotechnologypharmaceutical nanotechnologybiopolymerspharmacologynanoparticle researchpharmacotherapynanomaterialspolymer sciencepharmaceutics

Antioxidant Effects of the Prenylated Flavonoid, Xanthohumol, on Corneal Epithelial Cells in Experimental Dry Eye Disease. (2021)

Anita Kirti GhoshRubina ThapaHarsh Nilesh HarianiMichael VolyanyukKaroline Anne OrloffSamatha AnkireddyKaren LaiAgne ZiniauskaiteEvan Benjamin Stubbs JrGiedrius KalesnykasJenni Johanna HakkarainenKelly Ann LangertSimon Kaja

antioxidant effectspharmacologyophthalmologycorneal epithelial cellsplant physiologyprenylated flavonoidbotany

Optimization of Critical Parameters for Coating of Polymeric Nanoparticles With Plasma Membrane Vesicles by Sonication. Scientific Reports (2021)

Feipeng YangMaleen H. CabeSean D. OgleVeronica SanchezKelly A. Langert

membrane technologymaterials sciencepolymer nanotechnologyplasma membrane vesiclesprotective coatingsbiomedical engineeringpolymeric nanoparticleschemical engineeringmaterials engineeringbenchmark studiessurface nanotechnologycritical parameterscoatingsnanomaterialspolymer sciencenanotechnologyadditive manufacturing

Poly(Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating the Prenylated Flavonoid, Xanthohumol, Protect Corneal Epithelial Cells From Dry Eye Disease-Associated Oxidative Stress. Pharmaceutics (2021)

Anita Kirti GhoshRubina ThapaHarsh Nilesh HarianiMichael VolyanyukSean David OgleKaroline Anne OrloffSamatha AnkireddyKaren LaiAgnė ŽiniauskaitėEvan Benjamin StubbsGiedrius KalesnykasJenni Johanna HakkarainenKelly Ann LangertSimon Kaja

pharmaceutical chemistrynanomedicineophthalmologycorneal epithelial cellsnanoparticlespharmaceutical practicepharmaceutical sciencesmedicinepharmaceutical caredrug deliverytherapeutic nanomaterialsprenylated flavonoidlactic-co-glycolic acidpharmacological researchpharmacologyfree radical biologynanoparticle researchpharmacotherapydrug discoveryoxidative stresspharmaceutics

Xanthohumol Protects Corneal Epithelial Cells in Experimental Models for Dry-Eye Disease. Investigative Ophthalmology & Visual Science (2020)

Anita K. GhoshRubina ThapaHarsh Nilesh HarianiAgne ZiniauskaiteSamatha AnkireddyKaroline A OrloffJenni J. HakkarainenGiedrius KalesnykasKelly LangertSimon Kaja

dermatologypharmacologyophthalmologyoptical propertiesdry-eye diseaseexperimental ophthalmologyexperimental models

1
2
3
10 / page

Kelly Langert

Assistant Professor

Loyola University Chicago

Affiliations

Stritch School of Medicine

Molecular Pharmacology and Neurosciences

Kelly Langert is currently serving as a Molecular Pharmacology And Neurosciences Assistant Professor at Loyola University Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kelly Langert

Loyola University Chicago

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4143957: Assessing Blood-Nerve Barrier Permeability to Nanoparticles Over the Course of Experimental Autoimmune Neuritis. Circulation (2024)

Chanpreet KaurMaleen CabeKelly Langert

immunologyexperimental autoimmune neuritisautoimmune diseasesneuroimmunologynanoparticlesblood-nerve barrier permeability

Blood Nerve Barrier Permeability Enables Nerve Targeting of Circulating Nanoparticles in Experimental Autoimmune Neuritis. Research Square (Research Square) (2024)

Kelly LangertChanpreet KaurEllaina VillarrealMaleen Cabe

immunologyneurologyexperimental autoimmune neuritisnanotechnologyneuroscience

Statin Targeted Treatment Against Intimal Hyperplasia Using Unique Chitosan-Plga Nanoparticles. JVS Vascular Science (2024)

Ashley PentonGloria Grace PolandMaleen CabeKelly LangertKristopher MaierVivian Gahtan

intimal hyperplasiananomedicinebiomedical engineeringunique chitosan-plga nanoparticlesvascular biologynanoparticle researchvascular diseasenanoparticlesvascular pharmacology

Targeted Drug Delivery of Leukomimetic Nanoparticles to Alleviate Peripheral Neuropathy in Charcot-Marie-Tooth 1x. Journal of Pharmacology and Experimental Therapeutics (2024)

Harshita KondetiMaleen CabeLauren SoehlkeKelly LangertCharles Abrams

neurologypharmacologynanomedicineperipheral neuropathydrug targetingleukomimetic nanoparticlesdrug delivery

Beyond Cholesterol Reduction: Statin Pleiotropy and Peripheral Arterial Disease. IntechOpen eBooks (2023)

Ashley PentonKelly A. LangertKristopher MaierVivian Gahtan

cardiologyperipheral arterial diseaseclinical lipidologypharmacologystatin pleiotropyhematologynephrologycholesterol reductioncardiovascular diseasehealth scienceshealth policy

Chitosan/Poly(Lactic-Co-Glycolic)Acid Nanoparticle Formulations With Finely-Tuned Size Distributions for Enhanced Mucoadhesion. Pharmaceutics (2022)

Feipeng YangMaleen CabeHope A. NowakKelly A. Langert

Antioxidant Effects of the Prenylated Flavonoid, Xanthohumol, on Corneal Epithelial Cells in Experimental Dry Eye Disease. (2021)

antioxidant effectspharmacologyophthalmologycorneal epithelial cellsplant physiologyprenylated flavonoidbotany

Optimization of Critical Parameters for Coating of Polymeric Nanoparticles With Plasma Membrane Vesicles by Sonication. Scientific Reports (2021)

Feipeng YangMaleen H. CabeSean D. OgleVeronica SanchezKelly A. Langert

Xanthohumol Protects Corneal Epithelial Cells in Experimental Models for Dry-Eye Disease. Investigative Ophthalmology & Visual Science (2020)

Anita K. GhoshRubina ThapaHarsh Nilesh HarianiAgne ZiniauskaiteSamatha AnkireddyKaroline A OrloffJenni J. HakkarainenGiedrius KalesnykasKelly LangertSimon Kaja

dermatologypharmacologyophthalmologyoptical propertiesdry-eye diseaseexperimental ophthalmologyexperimental models

1
2
3
10 / page

Similar Faculty Members

Jeffrey Goldberg

Institution

Stanford University

stem cell research

ophthalmology

Jena Steinle

Institution

Wayne State University

endothelial dysfunction

ophthalmology

Sanjoy K. Bhattacharya

Institution

University of Miami

ophthalmology

visual system

Claire Mitchell

Institution

University of Pennsylvania

neurodegenerative disease

neuroprotection

Seth Blackshaw

Institution

Johns Hopkins University

neuroscience

ophthalmology

Steven GONIAS

Institution

University of California, San Diego

urokinase receptor

protein science

John Ash

Institution

University of Pittsburgh

ophthalmology

neuroscience

Sharon DeMorrow

Institution

University of Texas at Austin

pharmacology

hepatology

David J. Calkins

Institution

Vanderbilt University

ophthalmology

visual system

Arthi Kanthasamy

Institution

University of Georgia

free radical biology

neuroprotection

Similar Faculty Members

Jeffrey Goldberg

Institution

Stanford University

stem cell research

ophthalmology

Jena Steinle

Institution

Wayne State University

endothelial dysfunction

ophthalmology

Sanjoy K. Bhattacharya

Institution

University of Miami

ophthalmology

visual system

Claire Mitchell

Institution

University of Pennsylvania

neurodegenerative disease

neuroprotection

Seth Blackshaw

Institution

Johns Hopkins University

neuroscience

ophthalmology

Steven GONIAS

Institution

University of California, San Diego

urokinase receptor

protein science

John Ash

Institution

University of Pittsburgh

ophthalmology

neuroscience

Sharon DeMorrow

Institution

University of Texas at Austin

pharmacology

hepatology

David J. Calkins

Institution

Vanderbilt University

ophthalmology

visual system

Arthi Kanthasamy

Institution

University of Georgia

free radical biology

neuroprotection